InsiderClue
Insiders · Profile

Newman Michael James

CSO and Director at Indaptus Therapeutics. Filing since 31 Jan 2022. CIK 0001876315

Company
Date
Role
Action
Shares
Amount
Of holding
INDP Indaptus Therapeutics, Inc.
1 Feb 2022
CSO and Director
Sold, plan not stated
14,130
$70.69K
1.0%
INDP Indaptus Therapeutics, Inc.
31 Jan 2022
CSO and Director
Sold, plan not stated
5,870
$29.35K
0.4%
2 decisions on file.